Sanofi SA added a new plant in Singapore to make vaccines and other medicines, as the French pharmaceutical group seeks to ...
SINGAPORE — French pharmaceutical giant Sanofi on Wednesday opened a 800 million Singapore dollar ($595 million) "evolutive ...
Two months after Sanofi completed construction in France of its innovative Modulus vaccine and biologics plant—which can be ...
Sanofi's $595m Singapore facility, Modulus, leverages advanced technology for rapid, flexible vaccine production, bolstering ...
The 58,000 sq m plant – Sanofi’s second factory in Singapore – will produce vaccines and other biopharmaceutical products ...
About 200 people with the condition will be recruited for the trial, which will start in 2025. Read more at straitstimes.com.
Clinical trials for a revolutionary vaccine to treat acne will be conducted by the National Skin Centre in partnership with ...
Hosted on MSN12h
Sanofi inaugurates $800m healthcare manufacturing facility in SGSanofi inaugurated its $800m healthcare manufacturing facility, Modulus, located in Tuas Biomedical Park to be operational in ...
The collaboration includes a phase 1 clinical study to start in the second quarter of 2025. The National Skin Centre Singapore, Sanofi, and the Agency for Science, Technology, and Research (A*STAR) ...
In ‘Destination Anywhere’, Melanie Oliveiro chats with Walter de Oude, founder of Chocolate Finance. De Oude tells us about his adventures in South Africa exploring the wineries, hiking trails and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback